Avoid common mistakes on your manuscript.
Editor,
We would like to share ideas on the publication “Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report [1].” Özkan, et al. noted that “We describe a case of MCD relapse after a second dose of inactive that patients should be informed accordingly [1].” We agree that COVID-19 vaccine can cause clinical problem including renal disorder. The present case might or might not be the result of COVID-19 vaccine. There is no pre-vaccination data on immune/renal status of the patient. It is difficult to conclude on any interrelationship. The possibility that the relapse is due to the background medical problem or concurrent medical disorder should be kept in mind. For example, after vaccination, the vaccine recipient might experience concurrent arbovirus infection [2]. The arbovirus infection is a rare but possible cause of minimal change disease [3].
References
Özkan G, Bayrakçı N, Karabağ S et al (2022) Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report. Int Urol Nephrol 54:971–972. https://doi.org/10.1007/s11255-021-02889-5
Kebayoon A, Wiwanitkit V (2021) Dengue after COVID-19 vaccination: possible and might be missed. Clin Appl Thromb Hemost 27:10760296211047228
Lizarraga KJ, Nayer A (2014) Dengue-associated kidney disease. J Nephropathol 3(2):57–62
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Sriwijitalai W declares that he/she has no conflict of interest. Wiwanitkit V declares that he/she has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sriwijitalai, W., Wiwanitkit, V. Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination. Int Urol Nephrol 54, 3299 (2022). https://doi.org/10.1007/s11255-022-03258-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03258-6